|Videos|February 27, 2023
Ascendia Pharmaceuticals - Sophisticated Formulations from Molecule to Formulation to Clinical
Author(s)Ascendia Pharma
Key Learning Objectives
- Ascendia is a specialty CDMO for biologicals and gene deliveries, as well as small molecules
- Ascendia is expert in sophisticated formulations, and well as cGMP sterile and non-sterile clinical trial and commercial manufacturing
- Ascendia is expanding its manufacturing capability to best serve customers and continue to be Partner of Choice for many of them
Newsletter
Get the essential updates shaping the future of pharma manufacturing and compliance—subscribe today to Pharmaceutical Technology and never miss a breakthrough.
Related Content
Trending on Pharmaceutical Technology
1
Drug Digest: Outsourcing Partnerships Fuel Global Biopharma Discovery and Scale-Up
2
Women in STEM: Early Phase Drug Development
3
Rare Disease Treatments: Navigating the Economics of Global Innovation
4
FDA Grants Priority Review For Pfizer’s Marstacimab for Hemophilia A or B
5